全文获取类型
收费全文 | 4204篇 |
免费 | 372篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 42篇 |
儿科学 | 98篇 |
妇产科学 | 77篇 |
基础医学 | 475篇 |
口腔科学 | 36篇 |
临床医学 | 564篇 |
内科学 | 917篇 |
皮肤病学 | 36篇 |
神经病学 | 379篇 |
特种医学 | 158篇 |
外科学 | 371篇 |
综合类 | 39篇 |
预防医学 | 603篇 |
眼科学 | 78篇 |
药学 | 368篇 |
中国医学 | 2篇 |
肿瘤学 | 340篇 |
出版年
2023年 | 16篇 |
2022年 | 34篇 |
2021年 | 96篇 |
2020年 | 51篇 |
2019年 | 85篇 |
2018年 | 91篇 |
2017年 | 71篇 |
2016年 | 83篇 |
2015年 | 101篇 |
2014年 | 127篇 |
2013年 | 188篇 |
2012年 | 258篇 |
2011年 | 320篇 |
2010年 | 159篇 |
2009年 | 164篇 |
2008年 | 291篇 |
2007年 | 273篇 |
2006年 | 254篇 |
2005年 | 255篇 |
2004年 | 239篇 |
2003年 | 221篇 |
2002年 | 222篇 |
2001年 | 73篇 |
2000年 | 69篇 |
1999年 | 68篇 |
1998年 | 43篇 |
1997年 | 54篇 |
1996年 | 33篇 |
1995年 | 38篇 |
1994年 | 24篇 |
1993年 | 20篇 |
1992年 | 42篇 |
1991年 | 40篇 |
1990年 | 38篇 |
1989年 | 32篇 |
1988年 | 39篇 |
1987年 | 26篇 |
1986年 | 25篇 |
1985年 | 28篇 |
1984年 | 22篇 |
1982年 | 19篇 |
1981年 | 18篇 |
1980年 | 23篇 |
1979年 | 16篇 |
1978年 | 17篇 |
1972年 | 14篇 |
1971年 | 14篇 |
1970年 | 13篇 |
1969年 | 15篇 |
1965年 | 12篇 |
排序方式: 共有4583条查询结果,搜索用时 31 毫秒
1.
2.
Sherry X Yang Richard M Simon Antoinette R Tan Diana Nguyen Sandra M Swain 《Clinical cancer research》2005,11(17):6226-6232
PURPOSE: To delineate gene expression patterns and profile changes in metastatic tumor biopsies at baseline and 1 month after treatment with the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor erlotinib in patients with metastatic breast cancer. EXPERIMENTAL DESIGN: Patients were treated with 150 mg of oral erlotinib daily. Gene expression profiles were measured with Affymetrix U133A GeneChip and immunohistochemistry was used to validate microarray findings. RESULTS: Estrogen receptor (ER) status by immunohistochemistry is nearly coincided with the two major expression clusters determined by expression of genes using unsupervised hierarchical clustering analysis. One of 10 patients had an EGFR-positive tumor detected by both microarray and immunohistochemistry. In this tumor, tissue inhibitor of metalloproteinases-3 and collagen type 1 alpha 2, which are the EGF-down-regulated growth repressors, were significantly increased by erlotinib. Gene changes in EGFR-negative tumors are those of G-protein-linked and cell surface receptor-linked signaling. Gene ontology comparison analysis pretreatment and posttreatment in EGFR-negative tumors revealed biological process categories that have more genes differentially expressed than expected by chance. Among 495 gene ontology categories, the significant differed gene ontology groups include G-protein-coupled receptor protein signaling (34 genes, P = 0.002) and cell surface receptor-linked signal transduction (74 genes, P = 0.007). CONCLUSIONS: ER status reflects the major difference in gene expression pattern in metastatic breast cancer. Erlotinib had effects on genes of EGFR signaling pathway in the EGFR-positive tumor and on gene ontology biological process categories or genes that have function in signal transduction in EGFR-negative tumors. 相似文献
3.
BACKGROUND: Solid organ transplant recipients may develop numerous or life-threatening skin cancers. In addition to aggressive standard treatment of skin cancer, reduction of immunosuppression has been considered an adjuvant therapeutic strategy, albeit without direct proof of efficacy. OBJECTIVE: To review the rationale for and evidence supporting the efficacy of reduction of immunosuppression for severe skin cancer in transplant recipients. METHODS: Review of the literature regarding direct and indirect evidence on reduction of immunosuppression for transplant-associated skin cancer. RESULTS: Although there are no randomized controlled trials of reduction of immunosuppression as a therapeutic intervention for transplant patients with skin cancer, multiple lines of evidence suggest that this strategy may be an effective adjuvant therapy. A randomized trial has demonstrated a lower incidence of skin cancer in transplant recipients after reduction of immunosuppression, albeit in a cohort not previously affected by skin cancer. Case series of reduction or cessation of immunosuppression demonstrate a lower incidence of skin cancer or improved outcomes of preexisting skin cancer. Lower overall immunosuppression is associated with a lower incidence of skin cancer. Multiple cancers affecting the skin have been shown to regress with reduction of immunosuppression. CONCLUSIONS: Reduction of immunosuppression may be an effective adjuvant therapeutic strategy when confronting severe transplant-associated skin cancer. The risks of reduction of immunosuppression must be better defined, and randomized trials of this strategy are necessary. 相似文献
4.
5.
6.
7.
R J Ulshafer E L Clausnitzer D M Sherry A Szél P R?hlich 《Experimental eye research》1990,51(2):209-216
Immunoreactivities of two monoclonal antibodies (MAbs) that recognize cone photopigments were tested in the retinas of congenitally blind retinal degenerate (rd) chicks and compared to normally sighted carrier chicks, heterozygous for the mutation. MAb OS-2 had been previously determined to label rod and most cone outer segment membranes in normal chick retinas and is believed to bind to an epitope that is common to several photopigments in chickens. MAb COS-1 labels specifically middle-to-long-wavelength-sensitive cone photopigments in a number of vertebrate species. In rd chicks MAb OS-2 labeled the same number of rod outer segments at the same densities as carrier chicks. However, cone outer segments were less frequently and significantly less heavily labeled with this MAb at all ages tested (1 day, 1 week and 2 weeks post hatching). MAb COS-1 labeled the same number of cone outer segments in both rd and carrier retinas at 1 day of age, however, those outer segments that were labeled in rd specimens had significantly fewer gold particles on them. At both 1 week and 2 weeks of age, rd chick retinas had a significant reduction in numbers of cone outer segments labeled by COS-1. These findings support the hypothesis that the cone photopigment protein is abnormal in the rd chick model of hereditary blindness and retinal degeneration. 相似文献
8.
Symptom Clusters in Patients With High-Grade Glioma 总被引:2,自引:0,他引:2
9.
10.